MedTrace Logo

Study of Cytrix Use in Pelvic Floor Prolapse Treatment

NCT01244165 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2010-11-19

No results posted yet for this study

Summary

To evaluate safety and effectiveness of using the fetal bovine dermis (Cytrix) in the treatment of pelvic organ prolapse.

Conditions

  • Vaginal Vault Prolapse

Interventions

DEVICE

Cytrix

OTHER

Other treatments for pelvic organ prolapse

Treatments for pelvic organ prolapse using other products (standard of care for treatment of pelvic organ prolapse)

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Oscar A Aguirre, MD · Milestone Medical Research

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-01-31
Primary Completion
2006-10-31
Completion
2006-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01244165 on ClinicalTrials.gov